Tuesday, November 6, 2018

Trevena Inc shares plunged 45 percent on Friday after the U.S. Food and Drug Administration declined to approve its opioid injection for managing acute pain, citing inadequate safety data.


from Reuters: Health News https://ift.tt/2CX7v5W

Related Posts:

  • LATEST HEALTH NEWSAllergan Plc on Thursday sued Pfizer Inc to require its rival to cover any damages it is forced to pay as a result of hundreds of lawsuits claiming Allergan deceptively marketed an opioid it acquired from a company Pfizer bou… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Cannabis use by mothers or fathers during pregnancy, or even only before pregnancy, is associated with an increased risk of psychotic-like episodes in their children, a Dutch study suggests. from Reute… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Parents who talk or text on cell phones while driving with their kids in the car are also more likely to engage in other risky driving behaviors, including not wearing a seat belt or driving under the influ… Read More
  • LATEST HEALTH NEWSIt will be complicated and perhaps impossible to use a vaccine to tackle Democratic Republic of Congo's new Ebola outbreak, the World Health Organization's emergency response chief said on Thursday. from Reuters: Health … Read More
  • LATEST HEALTH NEWS(Reuters Health) - Children with autism may be better able to understand facial expressions and improve their social skills by using a Google Glass headset and smartphone app, a small pilot study suggests. from Reuters: … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner